Mettez-vous hors ligne avec l'application Player FM !
#23 Matthew Johnson: The Forefront of Psilocybin, Ecstasy, and Psychedelics as Treatment for Addiction
Série archivée ("Flux inactif" status)
When? This feed was archived on August 01, 2022 20:07 (). Last successful fetch was on January 15, 2022 02:59 ()
Why? Flux inactif status. Nos serveurs ont été incapables de récupérer un flux de podcast valide pour une période prolongée.
What now? You might be able to find a more up-to-date version using the search function. This series will no longer be checked for updates. If you believe this to be in error, please check if the publisher's feed link below is valid and contact support to request the feed be restored or if you have any other concerns about this.
Manage episode 299520598 series 2855068
On episode 23 of Business, Life, and Ayahuasca, we are pleased to have a guest that is at the forefront of psychedelic research, Dr. Matthew Johnson. Dr. Matthew Johnson is a professor of psychiatry and behavioral sciences at Johns Hopkins University. In 2014 he developed and published the first research on psychedelic treatment of tobacco addiction. Furthermore Dr. Johnson and colleagues published the largest study of psilocybin in treating cancer distress in 2016. Dr. Matthew Johnson expands upon these topics and many more in this episode of Business, Life, and Ayahuasca. As always, this episode is brought to you by Soltara Healing Center.
Connect with Matthew Johnson
Website- https://www.hopkinsmedicine.org/profiles/details/matthew-johnson
Twitter- @Drug_Researcher
Connect with Daniel Cleland
Website - http://danielcleland.com/
Instagram - @danielccleland
Facebook - @danielccleland
Sign up for my Newsletter: http://danielcleland.com/
Subscribe to my YouTube channel: https://www.youtube.com/c/DanielCleland
Subscribe to the podcast:
28 episodes
Série archivée ("Flux inactif" status)
When? This feed was archived on August 01, 2022 20:07 (). Last successful fetch was on January 15, 2022 02:59 ()
Why? Flux inactif status. Nos serveurs ont été incapables de récupérer un flux de podcast valide pour une période prolongée.
What now? You might be able to find a more up-to-date version using the search function. This series will no longer be checked for updates. If you believe this to be in error, please check if the publisher's feed link below is valid and contact support to request the feed be restored or if you have any other concerns about this.
Manage episode 299520598 series 2855068
On episode 23 of Business, Life, and Ayahuasca, we are pleased to have a guest that is at the forefront of psychedelic research, Dr. Matthew Johnson. Dr. Matthew Johnson is a professor of psychiatry and behavioral sciences at Johns Hopkins University. In 2014 he developed and published the first research on psychedelic treatment of tobacco addiction. Furthermore Dr. Johnson and colleagues published the largest study of psilocybin in treating cancer distress in 2016. Dr. Matthew Johnson expands upon these topics and many more in this episode of Business, Life, and Ayahuasca. As always, this episode is brought to you by Soltara Healing Center.
Connect with Matthew Johnson
Website- https://www.hopkinsmedicine.org/profiles/details/matthew-johnson
Twitter- @Drug_Researcher
Connect with Daniel Cleland
Website - http://danielcleland.com/
Instagram - @danielccleland
Facebook - @danielccleland
Sign up for my Newsletter: http://danielcleland.com/
Subscribe to my YouTube channel: https://www.youtube.com/c/DanielCleland
Subscribe to the podcast:
28 episodes
Tous les épisodes
×Bienvenue sur Lecteur FM!
Lecteur FM recherche sur Internet des podcasts de haute qualité que vous pourrez apprécier dès maintenant. C'est la meilleure application de podcast et fonctionne sur Android, iPhone et le Web. Inscrivez-vous pour synchroniser les abonnements sur tous les appareils.